Status:
COMPLETED
Effects of Inspiratory Muscle Training on Shortness of Breath (Dyspnea) and Postural Control in Patients With COPD
Lead Sponsor:
KU Leuven
Conditions:
Copd
Inspiratory Muscle Weakness
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
Shortness of breath (dyspnea) is an important symptom during physical exertion in patients with chronic obstructive pulmonary disease (COPD) and is related to respiratory muscle weakness. Dyspnea is a...
Detailed Description
The purpose of this clinical trial is to elucidate mechanisms of dyspnea relief and improvements in postural control after inspiratory muscle training (IMT) in patients with COPD. An endurance cycle ...
Eligibility Criteria
Inclusion
- Clinical Diagnosis of COPD
- Inspiratory Muscle Weakness (Pi,max \<70% predicted or \< 60 cmH2O)
- Baseline dyspnea index (BDI) \< 7
- Peripheral muscle fatigue present after CPET
Exclusion
- Major cardiovascular
- Limiting exercise capacity more than pulmonary function impairment
- Severe orthopedic with major impact on daily activities
- Psychiatric or cognitive disorders
- Progressive neurological or neuromuscular disorders
- Longterm O2 therapy
- Previous inclusion in rehabilitation program (\<1 year)
Key Trial Info
Start Date :
February 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03240640
Start Date
February 1 2017
End Date
January 31 2022
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Leuven
Leuven, Belgium, 3000